This conclusion is based on: 1) the down regulation of AXL, EGFR, IGF-1R and PDGFRβ in ShRUNX2 knocked down melanoma cell lines or RUNX2-specific U1 Adaptors-transfected melanoma cells. This evidence concerns the gene RUNX2 and melanoma.